Check out this forum today, featuring Dr. Gruber and other leading experts in the field!
Live webcast will stream on Tuesday, December 3, 2019 Noon-1pm ET There is no registration required to watch the event online.
An on-demand video will be posted. Questions for the panelists in advance: email@example.com
In the last decade, Americans’ relationship with cannabis has transformed: Today, dozens of states have legalized marijuana for medical or recreational use and American farmers can grow hemp on an industrial scale. Meanwhile, shoppers can find cannabidiol (CBD), which is derived from cannabis but does not produce a “high” like marijuana, in everything from oils to vapes, chocolate bars, cosmetics—even dog treats. Some say CBD can relieve stress, pain, anxiety, and more, with no side effects. But the evidence for many of these claims is limited, and state and federal laws around the sale of CBD are still evolving. Drawing on a newly-released poll by POLITICO and the Harvard Chan School, this Forum will examine public attitudes toward CBD products and recreational marijuana. Panelists will discuss the current state of policy and research regarding recreational marijuana in particular, and consider various solutions that have emerged to understand and regulate these rapidly growing industries.
Part of: Policy Controversies.
Presented jointly with POLITICO
Paul Demko, Cannabis Editor, POLITICO
Robert Blendon, Professor of Health Policy and Political Analysis, Harvard T.H. Chan School of Public Health and Harvard Kennedy School
Staci Gruber, Director, Cognitive and Clinical Neuroimaging Core; Director, Marijuana Investigations for Neuroscientific Discovery (MIND) Program at McLean Hospital; Associate Professor of Psychiatry, Harvard Medical School
David Grelotti, Medical Director, Center for Medicinal Cannabis Research at University of California San Diego School of Medicine, and Associate Clinical Professor of Psychiatry
Ways to Watch — No Registration Required to Watch Online